Skip to Main Content

Editor’s note: A recording of the conversation is embedded below.

Nearly two dozen biopharmaceutical entities have signed on to be a part of the Covid R&D alliance, a coalition to pool resources and accelerate research on how to best combat the pandemic.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED